Navigation Links
Cytox Raises Pre-Series A Financing From Management and Existing UK Investors, Welcomes First US Investors
Date:6/23/2009

LONDON, June 24 /PRNewswire/ -- Cytox Limited, a UK-based neuroscience company that provides blood biomarker services to the pharmaceutical industry for Alzheimer's disease (AD) clinical trials, has announced completion of a pre-Series A funding round of GBP 600,000 (US$ 1 million).

Proceeds will be used to advance commercialization of the company's testing services for AD and mild cognitive impairment (MCI). Cytox's biomarkers help confirm the AD diagnosis, predict which patients with MCI will convert to AD and provide information about individuals' likely responses to drug therapy.

Cytox's services enable companies to conduct more effective clinical trials with patients at the earliest stages of this devastating disease, offering the greatest hope of prevention and cure. The company's tests require only a single blood draw from the patient, which is significantly less invasive than tests requiring cerebrospinal fluid obtained by lumbar puncture (spinal tap) and quicker and cheaper than repeated imaging techniques (MRI).

Cytox's blood biomarkers have been validated for use in FDA trials in a recent clinical study, which was conducted in collaboration with the Oxford Project to Investigate Memory and Aging (OPTIMA) and supported by an Exceptional Grant for Research & Development from Advantage West Midlands. Future clinical trials are in planning to support FDA approval of the blood tests as a diagnostic test of dementia risk.

Management and existing UK investors were joined in the round by MASA Life Sciences LP, the first US institutional investor, and US angels, including Dr. Jim Foght, who joins the company as an advisor.

Commenting on the continued support from Midven Limited, the lead investor in Cytox through its investment from the Advantage Growth Fund, Roger Wood, Director of Midven, observed, "We are pleased to re-invest in Cytox. These are exciting times for
'/>"/>

SOURCE Cytox Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Obesity Greatly Raises Endometrial Cancer Risk
2. Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment
3. EUROPACE raises remote monitoring profile
4. Deploying the Power of Music to Save Lives West Africas Most Beloved Singer Raises His Voice to End Malaria
5. Roux-en-Y weight loss surgery raises kidney stone risk
6. National Kidney Foundations 23rd Annual Maryland Golf Classic Raises Funds to Fight Kidney Disease
7. Psoriasis Raises Risk of Heart Attack, Stroke, Death
8. Finding Raises Hope for Treating ALS
9. As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness
10. Heart Damage After Vascular Surgery Raises Death Risks
11. Satellite Healthcare Raises Kidney Awareness in Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... On Tuesday, September 16th, 2014, at 8:00 p.m. ... “KC After Dark.” Hosted by top WRNW1 host, ... every Tuesday at 8:00 p.m. EST. WRNW1 had a promotion ... and because of the amazing turnout for their first show, ... 500 callers. , During this comical, yet professional show, ...
(Date:9/22/2014)... September 22, 2014 The Philadelphia 100, ... Greater Philadelphia region each year, is considered a hallmark ... manufacturer MK Precision is proud to announce it has ... MK Precision will attend the Philadelphia 100 ... the premiere business events of the year, as well ...
(Date:9/22/2014)... 2014 (HealthDay News) -- All sexually active women ... common sexually transmitted infections: chlamydia and gonorrhea, according ... Task Force. The task force noted ... 24 years of age and pregnant women. ... noticeable symptoms. As a result, many infections go ...
(Date:9/22/2014)... Amy Norton HealthDay Reporter ... may fare better when newborn intensive care units (NICU) set ... infants, a new study finds. Researchers at one children,s ... and were less distressed when their NICU switched from the ... findings, published online Sept. 22 in the journal Pediatrics ...
(Date:9/22/2014)... seems futuristic, if not impossible. But with a ... researchers at University of California, San Diego School ... an entire, functional eye a reality. , "A ... for vision restoration," said Jeffrey Goldberg, MD, PhD, ... at University of Pittsburg Medical Center and Boston ...
Breaking Medicine News(10 mins):Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Looking ahead: Whole eye transplant under development 2
... The Autism Research Institute states that many of those ... appropriately diagnosed and treated may result in marked improvementATLANTA, ... every 20 seconds in the US. Autism is ... AIDS combined. The Federal Centers for Disease Control ...
... SANTA MONICA, Calif., April 6 Cord Blood America, Inc. ... preservation company ( http://www.cordblood-america.com ) ... to families nationwide and internationally, is pleased to announce that ... long term debt by approximately $750,000, or 12 percent. ...
... place in line at local emergency departments and ... has selected Trevelino/Keller Communications Group, Inc., one of ... launch the company nationally and build out its ... Alabama and Florida -- as it pursues national ...
... a systemic disease or an autoimmune disorder in which the ... of cells called the synovium that lines and lubricates the ... and crippling stiffness, particularly of the hands and feet. It ... mobility and quality of life. RA cannot be confirmed or ...
... solutions provider, is pleased to announce that its entire suite of ... , ... Charlotte, NC (PRWEB) April 6, 2009 -- IQMax, ... that its entire suite of healthcare solutions is available on Blackberry® ...
... high blood pressure and heart disease during a clinical trial for osteoarthritis. ... ... Company, a Bendigo based company who manufactures a topical pain relief lotion ... trial for their flagship product, Elmore Oil., , ,The trial was headed ...
Cached Medicine News:Health News:Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009 2Health News:Cord Blood Announces $1.75 Million Reduction in Long Term Debt 2Health News:Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 3Health News:IQMax Delivers Healthcare Solutions to Blackberry Devices 2Health News:Arthritis Trial Leads to Potential Cure for High Blood Pressure 2
(Date:9/22/2014)... Calif. , Sept. 22, 2014 Avanir ... that it is offering to sell $200 million of ... Morgan, Deutsche Bank Securities and BofA Merrill Lynch are ... to grant the underwriters a 30-day option to purchase ... shares to be sold in the offering are being ...
(Date:9/22/2014)... , September 22, 2014 ... September 25   The second edition of ... are excited to announce the final nominations for the ... announced on the evening of September 25 at The Taj Mahal Palace, ... from applicants based on a variety of qualitative and ...
(Date:9/22/2014)... 22, 2014 Decision Resources Group finds that by ... to be worth $2 billion (U.S. dollars), increasing at a ... five years (to 2018). This growth comes as ... 2013 and 4.9 percent expected over the next three to ... small but highly competitive. The pharmaceutical market is dominated by ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3
... CPF Calls on Manufacturer and FDA to Expedite Review of ... The Coalition for Pulmonary Fibrosis (CPF) is calling this a ... a pivotal Phase III clinical trial is completed for Pirfenidone ... way for the first FDA-approved therapy to treat PF - ...
... Intellectual property based on breakthrough research from a ... Montreal Heart Institute Research Centre, Canada.TOULOUSE, France and ... SA (Cerenis), a privately held pharmaceutical company developing ... metabolic diseases, today announced that it has in-licensed ...
Cached Medicine Technology:Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 2Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 3Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis 2
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Minimal M9CA Broth...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
...
Medicine Products: